Get the Stockscreener App
79.00
10.63%
-9.40
After Hours:
80.00
1.00
+1.27%
Sol Gel Technologies Ltd stock is traded at $79.00, with a volume of 37,281.
It is down -10.63% in the last 24 hours and up +22.10% over the past month.
Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted.
See More
Previous Close:
$88.40
Open:
$89.7
24h Volume:
37,281
Relative Volume:
1.59
Market Cap:
$220.08M
Revenue:
$23.93M
Net Income/Loss:
$-3.41M
P/E Ratio:
-69.30
EPS:
-1.14
Net Cash Flow:
$-33.87M
1W Performance:
-11.39%
1M Performance:
+22.10%
6M Performance:
+182.55%
1Y Performance:
+1,214%
1-Day Range:
$71.01
$89.70
1-Week Range:
$71.01
$97.97
52-Week Range:
$4.018
$97.97
Sol Gel Technologies Ltd Stock (SLGL) Company Profile
Name
Sol Gel Technologies Ltd
Sector
Industry
Phone
-
Address
-
Compare SLGL vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SLGL
Sol Gel Technologies Ltd
|
79.00 | 246.26M | 23.93M | -3.41M | -33.87M | -1.14 |
|
VRTX
Vertex Pharmaceuticals Inc
|
460.82 | 121.40B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
764.93 | 83.25B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
728.11 | 46.39B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
320.51 | 43.41B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
292.94 | 33.09B | 5.36B | 287.73M | 924.18M | 2.5229 |
Sol Gel Technologies Ltd Stock (SLGL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-19-24 | Downgrade | Raymond James | Strong Buy → Outperform |
| Oct-21-22 | Resumed | Jefferies | Hold |
| Dec-31-19 | Reiterated | H.C. Wainwright | Buy |
| Dec-31-19 | Reiterated | JMP Securities | Mkt Outperform |
Sol Gel Technologies Ltd Stock (SLGL) Latest News
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
Sol-Gel Technologies (SLGL) to Release Earnings on Wednesday - MarketBeat
Short Interest in Sol-Gel Technologies Ltd. (NASDAQ:SLGL) Decreases By 23.4% - MarketBeat
Aug Analyst Calls: Is Sol Gel Technologies Ltd gaining market shareJuly 2025 Levels & Free Safe Entry Trade Signal Reports - baoquankhu1.vn
SLGL Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Form 144 shows insider sale examples (SLGL) via Oppenheimer & Co. - Stock Titan
Opaleye Management Inc. Increases Stake in Sol-Gel Technologies Ltd - GuruFocus
Itzik Yosef to sell 1,170 SLGL ordinary shares (NASDAQ: SLGL) - Stock Titan
Sol-Gel Hard Coating Market Forecast 2026-2036: Market to Reach USD 4.9 Billion by 2036 at 13.6% CAGR - openPR.com
Is Sol Gel Technologies Ltd. impacted by rising ratesQuarterly Investment Review & Free High Return Stock Watch Alerts - mfd.ru
Trading Recap: Is Sol Gel Technologies Ltd stock heavily shorted2025 Key Highlights & Weekly Breakout Watchlists - baoquankhu1.vn
Opaleye Management Inc. (SLGL) reports open-market Sol-Gel share purchase - Stock Titan
Market Fear: Will Sol Gel Technologies Ltd. stock deliver consistent dividendsDay Trade & Smart Investment Allocation Insights - mfd.ru
Sol-Gel Technologies Ltd. (NASDAQ:SLGL) Short Interest Update - MarketBeat
Does Sol Gel Technologies Ltd. meet Warren Buffett’s criteria2025 Big Picture & Daily Entry Point Trade Alerts - mfd.ru
Can Sol Gel Technologies Ltd. maintain its current growth rateWeekly Trend Summary & Reliable Volume Spike Alerts - mfd.ru
Why is Sol Gel Technologies Ltd. stock going upWeekly Risk Report & AI Powered Buy/Sell Recommendations - mfd.ru
Sol-Gel Technologies (NASDAQ:SLGL) shareholders have earned a 940% return over the last year - Yahoo Finance
Aug Patterns: Whats the RSI of Sol Gel Technologies Ltd stockJuly 2025 EndofMonth & Fast Momentum Stock Entry Tips - baoquankhu1.vn
Aug PostEarnings: Can Sol Gel Technologies Ltd beat the S P 500July 2025 Spike Watch & High Accuracy Swing Entry Alerts - baoquankhu1.vn
Sol-Gel Technologies (SLGL) Price Target Increased by 120.00% to 112.20 - Nasdaq
Decliners Report: Is Sol Gel Technologies Ltd impacted by rising rates2025 Geopolitical Influence & Safe Entry Zone Identification - baoquankhu1.vn
Risk Off: Does Stellar V Capital Corp Debt Equity Composite Units have strong fundamentalsJuly 2025 Trends & Stepwise Entry and Exit Trade Signals - baoquankhu1.vn
Sol-Gel Technologies Ltd. (NASDAQ:SLGL) Short Interest Up 78.3% in January - MarketBeat
Is Sol Gel Technologies Ltd. stock heavily shortedTrade Volume Report & Long Hold Capital Preservation Plans - mfd.ru
Can Sol Gel Technologies Ltd. outperform in the next rallyJuly 2025 Short Interest & High Yield Stock Recommendations - mfd.ru
Sol-Gel Technologies (NASDAQ:SLGL) Major Shareholder Purchases $64,432.98 in Stock - Defense World
Sol-Gel Technologies (NASDAQ:SLGL) Major Shareholder Acquires $122,926.61 in Stock - MarketBeat
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
Sol Gel Technologies stock price target raised to $110 from $50 at H.C. Wainwright By Investing.com - Investing.com South Africa
Sol Gel Technologies stock price target raised to $110 from $50 at H.C. Wainwright - Investing.com Nigeria
Sol-Gel Technologies (SLGL) Analyst Rating Update: Target Price Doubles | SLGL Stock News - GuruFocus
Financial Survey: Assembly Biosciences (NASDAQ:ASMB) and Sol-Gel Technologies (NASDAQ:SLGL) - Defense World
Sol-Gel Technologies: Downgrading To 'Hold' As Success Relies On Upcoming Q4 Catalyst - Seeking Alpha
Bear Alert: Can Falcons Beyond Global Inc deliver consistent dividendsTrade Performance Summary & Fast Momentum Entry Tips - baoquankhu1.vn
Here's Why We're Not At All Concerned With Sol-Gel Technologies' (NASDAQ:SLGL) Cash Burn Situation - simplywall.st
Value Recap: Is Sol Gel Technologies Ltd. undervalued by DCF analysisQuarterly Risk Review & Safe Investment Capital Preservation Plans - baoquankhu1.vn
Inflation Data: Can Sol Gel Technologies Ltd beat the S P 500Weekly Profit Recap & Weekly Chart Analysis and Trade Guides - baoquankhu1.vn
Short Interest in Sol-Gel Technologies Ltd. (NASDAQ:SLGL) Declines By 67.2% - MarketBeat
How rising interest rates impact Sol Gel Technologies Ltd. stockJuly 2025 PostEarnings & Low Risk Entry Point Guides - ulpravda.ru
Aug Weekly: Will Sol Gel Technologies Ltd. stock gain from lower inflation2025 Top Gainers & Real-Time Chart Pattern Alerts - ulpravda.ru
Support Test: How Sol Gel Technologies Ltd. stock reacts to bond yieldsJuly 2025 WrapUp & Expert-Curated Trade Recommendations - Улправда
Can Sol Gel Technologies Ltd. stock hit record highs againJuly 2025 Reactions & Precise Buy Zone Tips - Улправда
Is Sol Gel Technologies Ltd. stock supported by strong cash flowsJuly 2025 Chart Watch & Consistent Return Investment Signals - ulpravda.ru
How Sol Gel Technologies Ltd. stock reacts to bond yieldsJuly 2025 Fed Impact & AI Powered Buy/Sell Recommendations - ulpravda.ru
Does Sol Gel Technologies Ltd. stock trade at a discount to peersTrade Signal Summary & Short-Term High Return Ideas - Улправда
Can MMP Industries Limited Regain Lost Ground This QuarterStock Liquidity Analysis & Stay Ahead With Daily Market Discussions - bollywoodhelpline.com
Siddhika Coating Limited A Paint CompanyStock Rotation Strategies & Build Diversified Portfolios With Ease - bollywoodhelpline.com
Rosacea Market Research and Forecast Report 2025-2035: Galderma, AbbVie, Bausch Health, Journey Medical, and Sol-Gel Drive Innovation Through Expanded R&D and Clinical TrialsResearchAndMarkets.com - The AI Journal
FinancialContentRosacea Market Research and Forecast Report 2025-2035: Galderma, AbbVie, Bausch Health, Journey Medical, and Sol-Gel Drive Innovation Through Expanded R&D and Clinical TrialsResearchAndMarkets.com - FinancialContent
Opaleye Management Inc. Buys 22,497 Shares of Sol-Gel Technologies (NASDAQ:SLGL) Stock - Defense World
Sol Gel Technologies Ltd Stock (SLGL) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.69%
0.68%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):